NCT03532854View on ClinicalTrials.gov

Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

May 28, 2018

Primary Completion Date

August 25, 2018

Study Completion Date

January 30, 2019

Conditions

Healthy Male Volunteers

Interventions

DRUG

Valsartan

Valsartan P.O

DRUG

Ezetimibe/Rosuvastatin

Ezetimibe/Rosuvastatin P.O

Trial Locations (1)

07795

LG chem, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LG Chem

INDUSTRY

NCT03532854 - Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802 | Biotech Hunter | Biotech Hunter